These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Meningitis and skin reaction after intravenous immune globulin therapy. Catteau B; Delaporte E; Piette F Ann Intern Med; 1997 Dec; 127(12):1130. PubMed ID: 9412321 [No Abstract] [Full Text] [Related]
5. [Use of propranolol in the treatment of migraine]. Klimek A; Nevodnichiĭ A Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(1):75-8. PubMed ID: 7064609 [TBL] [Abstract][Full Text] [Related]
6. Second response to immunoglobulin in recurrent Guillain-Barré syndrome. Nagappan R; Barker J N Z Med J; 1998 Nov; 111(1077):433-4. PubMed ID: 9861925 [TBL] [Abstract][Full Text] [Related]
7. Single-dose intravenous immune globulin for treatment of Guillain-Barré syndrome. McGhee B; Jarjour IT Am J Hosp Pharm; 1994 Jan; 51(1):97-9. PubMed ID: 8135270 [No Abstract] [Full Text] [Related]
8. High-dose intravenous immune globulin in the management of severe Guillain-Barre syndrome. Baskin E; Turkay S; Icagasioglu D; Tanzer F; Cevit O Turk J Pediatr; 1996; 38(1):119-23. PubMed ID: 8819632 [TBL] [Abstract][Full Text] [Related]
9. Treatment of Guillain-Barré syndrome with high-dose immune globulins combined with methylprednisolone: a pilot study. The Dutch Guillain-Barré Study Group. Ann Neurol; 1994 Jun; 35(6):749-52. PubMed ID: 8210234 [TBL] [Abstract][Full Text] [Related]
10. Observations on the efficacy of propranolol for the prophylaxis of migraine. Rosen JA Ann Neurol; 1983 Jan; 13(1):92-3. PubMed ID: 6338806 [TBL] [Abstract][Full Text] [Related]
11. Compatibility problems after intravenous immunoglobulin--a case report. Sulochana PV; Mathai J; Sathyabhama S; Augustine P Indian J Pathol Microbiol; 1998 Oct; 41(4):495-8. PubMed ID: 9866917 [TBL] [Abstract][Full Text] [Related]
12. [Beta blockers in migraine prophylaxis]. Shimizu T Brain Nerve; 2009 Oct; 61(10):1125-30. PubMed ID: 19882938 [TBL] [Abstract][Full Text] [Related]
13. Recurrent Guillain-Barre syndrome as a complication of immune reconstitution in HIV. Makela P; Howe L; Glover S; Ferguson I; Pinto A; Gompels M J Infect; 2002 Jan; 44(1):47-9. PubMed ID: 11972420 [No Abstract] [Full Text] [Related]
14. On the etiopathogenesis of migraine: a possible link between the amines and endorphin hypotheses. Agnoli A; Denaro A; Ceci E; Falaschi P Adv Neurol; 1982; 33():99-106. PubMed ID: 6119897 [No Abstract] [Full Text] [Related]
15. Neutropenia in a patient receiving intravenous immune globulin. Tam DA; Morton LD; Stroncek DF; Leshner RT J Neuroimmunol; 1996 Feb; 64(2):175-8. PubMed ID: 8632059 [TBL] [Abstract][Full Text] [Related]
16. Intravenous immune globulin. Gabor EP West J Med; 1995 Mar; 162(3):277-8. PubMed ID: 7725726 [No Abstract] [Full Text] [Related]
17. [The treatment of juvenile migraine using flunarizine or propranolol]. Lütschg J; Vassella F Schweiz Med Wochenschr; 1990 Nov; 120(46):1731-6. PubMed ID: 2251492 [TBL] [Abstract][Full Text] [Related]
18. Drug stop: migraine headache. Current therapy. Ambielli M J Neurosurg Nurs; 1982 Aug; 14(4):203-6. PubMed ID: 6922159 [No Abstract] [Full Text] [Related]
19. Biofeedback assisted diaphragmatic breathing and systematic relaxation versus propranolol in long term prophylaxis of migraine. Kaushik R; Kaushik RM; Mahajan SK; Rajesh V Complement Ther Med; 2005 Sep; 13(3):165-74. PubMed ID: 16150370 [TBL] [Abstract][Full Text] [Related]